A review of bispecific antibodies and antibody constructs in oncology and clinical challenges-Reference-Cited by-同舟云学术

A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

Published:2019-09 Issue: Volume:201 Page:103-119
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Suurs Frans V.,Lub-de Hooge Marjolijn N.,de Vries Elisabeth G.E.,de Groot Derk Jan A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference172 articles.

1. First-in-human phase 1/2 study of MCLA-128, a full length IgG1 bispecific antibody targeting HER2 and HER3: Final phase 1 data and preliminary activity in HER2+ metastatic breast cancer (MBC);Alsina;Journal of Clinical Oncology,2017

2. Pretargeted imaging and therapy;Altai;Journal of Nuclear Medicine,2017

3. Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans;Amann;Cancer Immunology, Immunotherapy,2009

4. Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC);Argilés;Annals of Oncology,2017

5. Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: Description of a novel modular targeting system;Arndt;Leukemia,2014

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General Quasi-Equilibrium Multivalent Binding Model to Study Diverse and Complex Drug-Receptor Interactions of Biologics;2024-01-25

2. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs;Experimental Hematology & Oncology;2024-01-22

3. Impact of structural modifications of IgG antibodies on effector functions;Frontiers in Immunology;2024-01-08

4. Anticancer therapeutic agents;Encyclopedia of Toxicology;2024

5. Bispecific antibody drug conjugates: Making 1+1>2;Acta Pharmaceutica Sinica B;2024-01